reference/23507047

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23507047

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1932-6203
issueIdentifier	9
pageRange	e23379-
publicationName	PLoS ONE
startingPage	e23379
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c047f62c91dfeb99662242468bb91af6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fbca75696a9507f7c06f14f9c3a5d2b6
bibliographicCitation	Dabora SL, Franz DN, Ashwal S, Sagalowsky A, DiMario FJ, Miles D, Cutler D, Krueger D, Uppot RN, Rabenou R, Camposano S, Paolini J, Fennessy F, Lee N, Woodrum C, Manola J, Garber J, Thiele EA. Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease. PLoS ONE. 2011 Sep 06;6(9):e23379. doi: 10.1371/journal.pone.0023379.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13693e1bb6e275352198500f09957d3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_577c48303c35653b93b66d34b91bfaa7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6e95694df3806e2f386cde44e42776f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23acbef8bb9d1e844037d317c3ebda97 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7250-7391 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fbb138224606bcf41ddfbcfe4d3a54b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_854338a9ef408354b17b243e958ba973 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_559ca8398413a4a4176413f808bb0e17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e01ae1e712a751587822dab1f4dc3b9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc624d904d325567c2a819aad10f89c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a979ef706cf37c014c4489bc6e1e63a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47e8c788976e9ea63b6190880a28c94e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a129ef9e4f8310f0add4a62eba29a79 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73af8594832acb639293a38fc086e188 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2249caf1305750b0b00fc150abb9f63 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2899aac124f5e58ec7b5579901019618 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db1388c1506e73d508fed6fb37148bde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e87503443624c92b7205c3d3fd0a7550 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_141a6c50b198067dfffc13dedf2b5fac
date	2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21915260 https://doi.org/10.1371/journal.pone.0023379 https://pubmed.ncbi.nlm.nih.gov/PMC3167813
isPartOf	https://portal.issn.org/resource/ISSN/1932-6203 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33103
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease
discusses	http://id.nlm.nih.gov/mesh/M0279673 http://id.nlm.nih.gov/mesh/M0448397 http://id.nlm.nih.gov/mesh/M0029863
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014402Q000188 http://id.nlm.nih.gov/mesh/D020123Q000009 http://id.nlm.nih.gov/mesh/D042643Q000378 http://id.nlm.nih.gov/mesh/D007680Q000139 http://id.nlm.nih.gov/mesh/D020123Q000627 http://id.nlm.nih.gov/mesh/D000900Q000627 http://id.nlm.nih.gov/mesh/D000900Q000009 http://id.nlm.nih.gov/mesh/D018207Q000139
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008113Q000139 http://id.nlm.nih.gov/mesh/D008113Q000378 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D014402Q000378 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018207Q000378 http://id.nlm.nih.gov/mesh/D007680Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9e8529100bf9a4fba98ae6d36c6427de http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8337 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7078 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8989 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10230 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10128 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9529 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8066 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_646caaa7c99b02cebac462a51ebcdd71 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_823fcecddb856aff97395f6263c49881 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8392 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10298 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9683 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242749350 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129144708 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127788218 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129309629 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242963342 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127772503 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874

Predicate

Subject

isDiscussedBy

Total number of triples: 102.